STRO4

· New England Cell Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STRO4, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS) [Phase 2]